XML 55 R36.htm IDEA: XBRL DOCUMENT v3.25.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
12 Months Ended
Dec. 31, 2024
Accounting Policies [Abstract]  
SCHEDULE OF ACQUIRED EQUITY INTERESTS

 

Name of the MC 

Percentage of

Equity Interest

Acquired

  

Percentage of

Voting Interest

Held

 
Medical Corporation Shobikai   100%          0%
Medical Corporation Kowakai   100%   0%
Medical Corporation Nasukai   100%   0%
Medical Corporation Aikeikai   100%   0%
Medical Corporation Jukeikai   100%   0%
Medical Corporation Ritz Cosmetic Surgery   100%   0%
SCHEDULE OF LOCAL CURRENCY EXCHANGE RATES

Translation of amounts from local currency of the Company into US$1 has been made at the following exchange rates:

 

  

December 31,

2024

  

December 31,

2023

 
Current JPY: US$1 exchange rate   156.7890    141.0350 
Average JPY: US$1 exchange rate   151.4405    140.5261 
SCHEDULE OF PROPERTY AND EQUIPMENT ESTIMATED USEFUL LIVES

 

   Depreciation Method  Useful Life
Land  Not depreciated 
Buildings and facilities attached to buildings  Straight-line method  3 47 years
Machinery, equipment and automobiles  Declining balance method  2 15 years
Aircraft  Declining balance method  2 8 years
Software*  Straight-line method  5 years

 

 

* Represents software that is non-detachable to the hardware.
SCHEDULE OF ESTIMATED USEFUL LIVES OF INTANGIBLE ASSETS

The estimated useful lives of intangible assets are as follows:

 

    Useful Life
Patent use right   16 years
Trademarks   20 years
Customer Relationships   3 4 years
Others   3 years
SCHEDULE OF FAIR VALUE ON A RECURRING BASIS

Assets measured at fair value on a recurring basis as of December 31, 2024 and 2023 are summarized below.

 

  

Quoted

Prices in

Active

Markets for

Identical

Assets

(Level 1)

  

Significant

Other

Observable

Inputs

(Level 2)

  

Unobservable

Inputs

(Level 3)

  

Fair

Value at

December 31,

2024

 
Fair Value Measurements as of December 31, 2024
  

Quoted

Prices in

Active

Markets for

Identical

Assets

(Level 1)

  

Significant

Other

Observable

Inputs

(Level 2)

  

Unobservable

Inputs

(Level 3)

  

Fair

Value at

December 31,

2024

 
Long-term investments:                    
Equity investments at fair value with readily determinable fair value  $2,478,531            $2,478,531 

 

  

Quoted

Prices in

Active

Markets for

Identical

Assets

(Level 1)

  

Significant

Other

Observable

Inputs

(Level 2)

  

Unobservable

Inputs

(Level 3)

  

Fair

Value at

December 31,

2023

 
Fair Value Measurements as of December 31, 2023
  

Quoted

Prices in

Active

Markets for

Identical

Assets

(Level 1)

  

Significant

Other

Observable

Inputs

(Level 2)

  

Unobservable

Inputs

(Level 3)

  

Fair

Value at

December 31,

2023

 
Long-term investments:                
Equity investments at fair value with readily determinable fair value